StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) income statement

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3063% below fair value
$4.71−0.07 (-1.46%)

Close on Nov 19, 2026Market cap $778.28MP/E 6.1Yield –

Ironwood Pharmaceuticals Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
60.1%
Net margin
33.4%
Return on equity, FY2025
-8.5%

Financial strength

Current ratio
6.06
Debt to equity
–
Debt to assets
–
Cash to current liabilities
240.8%

Valuation

P/E ratio
6.1
Price to sales
2.00
Price to book
–
Dividend yield
–

See a number that looks wrong?